Alexa Bio Tech Private Limited - Due diligence report

A 360° intelligence report on Alexa Bio Tech Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

2009-11-25 Chandigarh, Chandigarh Active Unlisted Active Non-Compliant
Share
AB Alexa Bio Tech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Alexa Bio Tech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
44/100
Trust Score
Caution Indicated

Alexa Bio Tech Private Limited is assessed as Caution Indicated with a Trust Score of 44/100. Alexa Bio Tech Private Limited is an active private limited indian non-government company incorporated in 2009, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Alexa Bio Tech Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
44/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
25/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
25/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 25/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 1 open (7.22 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of India1 48.0 cr
Compliance Score: 25/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2015 - filings overdue.
  • Flagged by authority: MCA.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
OM PARKASH SINGLA 01234567 Director 01/04/2018 6 yrs Approved
RAKESH KUMAR 01234567 Director 01/04/2018 6 yrs Approved
SANDEEP KUMAR 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • OM PARKASH SINGLA has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2015 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
8 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 50
Growth signals & trust indicators
Asset base grew 1.42 - capacity expansion.
Operating for 16+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
Compliance score is weak (25/100).
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence38/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment26/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 7.22 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view40/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
12 Jan 2016
Director ceased
TEJ PAL GUPTA
Director ceased
PANKAJ GUPTA
30 Sep 2015
Last AGM held
Annual general meeting
31 Mar 2015
Latest balance sheet
Filed with ROC
08 Dec 2014
Securities allotted
2800000 Equity Shares Without Differential Rights - 2.80 cr raised
30 Nov 2014
Securities allotted
2800000 Equity Shares Without Differential Rights - 2.80 cr raised
29 Dec 2012
Securities allotted
1000000 Equity Shares Without Differential Rights - 1.00 cr raised
15 Dec 2012
Securities allotted
1000000 Equity Shares Without Differential Rights - 1.00 cr raised
01 Feb 2012
Director ceased
OM PARKASH SHARMA
09 Sep 2010
Charge created
Bank Of India - 7.22 cr
23 Jul 2010
Securities allotted
500000 Equity Shares Without Differential Rights - 50.00 Lakh raised
Securities allotted
490000 Equity Shares Without Differential Rights - 49.00 Lakh raised
30 Jun 2010
Securities allotted
500000 Equity Shares Without Differential Rights - 50.00 Lakh raised
16 May 2010
Director appointed
SANDEEP KUMAR (Director)
30 Mar 2010
Securities allotted
490000 Equity Shares Without Differential Rights - 49.00 Lakh raised
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 1 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2015 annual return.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Halmak Pharmaceuticals Private Limited U24230TG1997PTC026415 Na, Telangana, India
Synergy Formulation Private Limited U24231GJ2004PTC043698 Ahmadabad City, Gujarat, India
Sumeru Pharma Limited U24232TG2010PLC071400 Hyderabad, Telangana, India
Atharva Herbals Private Limited U24233MH2002PTC135183 Vasai, Maharashtra, India
V S Equipments And Automations Private Limited U28939MH2005PTC153604 Thane, Maharashtra, India
Dacca Oushadhalaya Pvt Ltd U24233WB1948PTC016705 Paschim Midnapore, West Bengal, India
First Lab Private Limited U24119OR2012PTC016156 Cuttack, Orissa, India
Dixit Polymer Private Limited U25200TG2011PTC075773 Manoharabad Mandal, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Alexa Bio Tech Private Limited before audits and certifications: compliance score 25/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Alexa Bio Tech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 25/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 45/100, margin trends, ownership structure and peer set for Alexa Bio Tech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 44/100, distress signals and MSME payment-delay disclosures - know whether Alexa Bio Tech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Alexa Bio Tech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Alexa Bio Tech Private Limited an active company?

Alexa Bio Tech Private Limited has MCA status “Active” with a compliance score of 25/100 (Caution Indicated).

Is Alexa Bio Tech Private Limited financially healthy?

Alexa Bio Tech Private Limited has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Alexa Bio Tech Private Limited?

Its overall Trust Score is 44/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Alexa Bio Tech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Alexa Bio Tech Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Alexa Bio Tech Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 25/100 (Caution Indicated).

Is it risky to lend to Alexa Bio Tech Private Limited?

Its Credit Risk Score is 25/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.